Metoprolol er half life
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest metoprolol has an elimination half-life of approximately 3 hours.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Metoprolol ER Half-Life: An Overview
Introduction to Metoprolol ER
Metoprolol is a selective β1-receptor antagonist commonly used to treat conditions such as hypertension, angina, and arrhythmias. The extended-release (ER) formulation of metoprolol is designed to provide a sustained therapeutic effect, improving patient compliance by reducing the frequency of dosing.
Pharmacokinetics of Metoprolol ER
Absorption and Distribution
Metoprolol is rapidly and completely absorbed after oral administration, with about 40% of the dose reaching systemic circulation due to first-pass metabolism. The drug is extensively distributed to extravascular tissues, with a distribution half-life of approximately 12 minutes.
Elimination Half-Life
The elimination half-life of metoprolol varies depending on the formulation and patient population. For the immediate-release formulation, the elimination half-life is approximately 3 to 3.5 hours . However, the extended-release formulation is designed to prolong the drug's action, resulting in a longer effective half-life. Studies indicate that the half-life of metoprolol ER can range from 4 to 6 hours.
Factors Influencing Half-Life
Several factors can influence the half-life of metoprolol. For instance, in patients with hepatic cirrhosis, the elimination half-life is significantly prolonged, averaging around 7.2 hours compared to 4.2 hours in healthy individuals. Additionally, the combination of metoprolol with other medications, such as ranitidine, can extend its half-life from 3-9 hours to approximately 6 hours.
Clinical Implications
Efficacy and Compliance
The extended-release formulation of metoprolol has been shown to be effective in providing 24-hour coverage, which is crucial for managing conditions like hypertension and angina. For example, a study comparing once-daily metoprolol ER with multiple daily doses of regular metoprolol found that the ER formulation was highly effective in suppressing daily and exercise-induced ischemia.
Variability in Plasma Levels
There is considerable variability in plasma levels of metoprolol among different patient populations. For instance, geriatric patients exhibit a wide range of peak plasma concentrations, which can be attributed to factors such as body weight, absorption rates, and first-pass metabolism.
Conclusion
Metoprolol ER is a widely used β1-receptor antagonist with a half-life ranging from 4 to 6 hours, depending on various factors such as patient health and concurrent medications. Its extended-release formulation ensures sustained therapeutic effects, improving patient compliance and efficacy in managing cardiovascular conditions. Understanding the pharmacokinetics and factors influencing the half-life of metoprolol ER is essential for optimizing its clinical use.
Sources and full results
Most relevant research papers on this topic
